Decreases Risk of Osteoporosis
Osteoporosis is a widespread disorder that causes substantial morbidity and mortality among the elderly. It is categorized as a progressive metabolic bone disease marked by decreased bone mass and damaging bone microstructural alterations, resulting in increased bone fragility and fracture risk. A leading reason for this condition in males is a decline in testosterone levels with age. Men are more likely to be connected with disability and mortality due to osteoporotic fractures than women, despite the more significant frequency in women. Later in men’s lives, the frequency of osteoporotic fractures proliferates. A reduction in bioavailable testosterone accompanies this.
Even though males generate much more testosterone than women, testosterone exerts powerful androgenic and anabolic effects that are crucial for both genders. For instance, testosterone strongly influences bone formation and maintenance. This process, also known as bone remodeling, involves the continuous formation and destruction of bone tissue. Three types of cells are involved in the process, with specific cells containing androgen receptors. In this mechanism, testosterone alters bone mass by activating the above-mentioned receptors. Osteoporosis occurs when the body breaks down bone tissue quicker than it forms new bone tissue.
